Pine Labs IPO GMP History
Pine Labs IPO has been listed on November 14, 2025 at a listing price of ₹242, against the issue price of ₹₹221 — a gain of ₹21 (+9.5%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Pine Labs IPO raised ₹3900.17 Cr. through its IPO at a price band of ₹210 to ₹221 per share, with a lot size of 67 shares. The IPO was open for subscription from 07 Nov 2025 to 11 Nov 2025.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 27 Aug, 12:02 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Pine Labs IPO dates
Key dates from opening to listing. Today is 3 October.
- Open 07 Nov 2025
- Close 11 Nov 2025
- Allotment 12 Nov 2025
- Refund/credit 13 Nov 2025
- Listing 14 Nov 2025
Pine Labs IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹₹221 |
|---|---|
| Listing gain / loss | +₹21 per share |
| Listing date | 14 Nov, 2025 |
| Actual listing price | ₹242 (+9.5%) |
Is Pine Labs IPO GMP reliable?
Grey market premium for Pine Labs IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Pine Labs IPO full review for a fundamentals-based assessment before making any grey market trades.
Pine Labs IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Pine Labs IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Pine Labs IPO
Pine Labs is a leading fintech company founded in 1998, initially focusing on providing payment processing solutions to large retail merchants. Over time, the company evolved into a comprehensive digital payments and merchant commerce platform, expanding its presence across India and other Asian markets. Pine Labs was co-founded by Rajul Garg, Tarun Upadhyay, and Sandeep Bakhshi, and later saw significant growth under the leadership of CEO Amrish Rau. The company has built a strong network of merchant partners, banks, and financial institutions, establishing itself as a key player in the digital payments ecosystem.
The company offers a wide range of products and services including point-of-sale (POS) machines, payment gateway solutions, buy-now-pay-later (BNPL) services, and merchant financing. Its business model is largely transaction-driven, earning revenue through payment processing fees, device leasing, and value-added financial services. Pine Labs focuses on enabling seamless omnichannel commerce for merchants, helping them accept digital payments, manage customer engagement, and access credit solutions. Its partnerships with banks and brands further strengthen its ability to offer tailored financial products to both merchants and consumers.
Frequently asked
What is the GMP of Pine Labs IPO?
The current Grey Market Premium (GMP) of Pine Labs IPO is not yet started or active in the market.
What is the Kostak Price of Pine Labs IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Pine Labs IPO is not available.
What is the Subject to Sauda Price of Pine Labs IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Pine Labs IPO?
Pine Labs IPO listed on November 14, 2025 at ₹242, against the issue price of ₹₹221 — a gain of +9.5%.
How did the GMP of Pine Labs IPO trend before listing?
The GMP of Pine Labs IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Pine Labs IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
